Reperio Health, the sole provider of instant-result at-home and onsite health screenings, reported on May 19 the successful closure of a $14 million funding round headed by Nashville-based Caduceus Capital Partners.
This investment will accelerate the national rollout of Reperio’s screening model, which offers an on-demand preventive care experience. The funding will scale ReperioCare, a platform that connects users with clinicians immediately after screenings. This unique real-time consultation feature offers instant, personalized insights.
Reperio’s FDA-cleared at-home kits include Bluetooth-enabled devices and a guided mobile app experience, offering readings for metrics including blood pressure, heart rate, body mass index, relative fat mass, blood glucose, total cholesterol, HDL cholesterol, LDL cholesterol and triglycerides. These less-than-30-minute screenings have resulted in preventive screening participation rates rising by over 200%, delivering four to eight times the return-on-investment for clients.
Reperio has achieved a 95% customer satisfaction rate and near-perfect client renewals across over 40 launches and thousands of screenings in just 18 months of commercialization.
